CUSIP: 22663K107 | NYSE | Healthcare · Biotechnology | Mid Cap | 595 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13G/AFMR LLC | 1,439,891 | 1.4% | Newly reported | Jul 31, 2026 | 31d ahead of 13F (15,840,219 sh) · −14,400,328 |
| 13G/AFarallon Capital Management, L.L.C. with Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Four Crossings Institutional Partners V, L.P., +10 more | 8,989,098 | 8.5% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 1,466 | $124.5K | 0.0% | Growth | Low | Tampa, FL | 2026-10-16 |